Screener
Vaxcyte, Inc. PCVX Total Liabilities & Equity
Total Liabilities & Equity at other companies
Other financials
Where this comes from
Reported directly by Vaxcyte, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.
The source filing: Vaxcyte, Inc.’s 10-Q, filed May 6, 2026.
- Filed
- May 6, 2026, 4:12 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001649094-26-000017
| Line item | March 31,2026 | December 31, 2025 |
|---|---|---|
| Stockholders' Equity | ||
| Preferred stock, $0.001 par value — 10,000,000 shares authorized at March 31, 2026 and December 31, 2025; no shares issued and outstanding at March 31, 2026 and December 31, 2025 | — | — |
| Common stock, $0.001 par value — 500,000,000 shares authorized at March 31, 2026 and December 31, 2025; 144,314,981 and 131,058,858 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively | 147 | 134 |
| Additional paid-in capital | 5,478,270 | 4,838,736 |
| Accumulated other comprehensive loss | (6,834) | 1,587 |
| Accumulated deficit | (2,475,569) | (2,154,947) |
| Total stockholders' equity | 2,996,014 | 2,685,510 |
| Total liabilities and stockholders' equity | $3,348,308 | $3,002,717 |
Item 1. Condensed Consolidated Financial Statements (unaudited)
FAQ
- What is Vaxcyte, Inc.'s total liabilities & equity?
- Vaxcyte, Inc. (PCVX) reported total liabilities & equity of $3.35B in Q1 2026.
- How has Vaxcyte, Inc.'s total liabilities & equity changed year-over-year?
- Vaxcyte, Inc.'s total liabilities & equity decreased by 0.9% year-over-year, from $3.38B to $3.35B.
- What is the long-term trend for Vaxcyte, Inc.'s total liabilities & equity?
- Over 5 years (2020 to 2025), Vaxcyte, Inc.'s total liabilities & equity has grown at a 50.2% compound annual growth rate (CAGR), from $392.83M to $3B.
- What does total liabilities & equity mean?
- Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.
Ask your AI about Vaxcyte, Inc.'s total liabilities & equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude